Free Cash Flow Chart

Historical Free Cash Flow Data

View and export this data back to 1999. Start Trial.
Date Value
July 31, 2026 -6.137M
April 30, 2026 -5.036M
January 31, 2026 3.816M
October 31, 2025 5.64M
July 31, 2025 7.24M
April 30, 2025 6.997M
January 31, 2025 -1.323M
October 31, 2024 -2.816M
July 31, 2024 -2.003M
April 30, 2024 -6.973M
January 31, 2024 -6.72M
October 31, 2023 -4.856M
July 31, 2023 -2.61M
April 30, 2023 1.10M
January 31, 2023 2.842M
October 31, 2022 5.875M
July 31, 2022 3.855M
April 30, 2022 4.113M
January 31, 2022 0.989M
October 31, 2021 -3.931M
July 31, 2021 -4.22M
April 30, 2021 -4.962M
January 31, 2021 -1.11M
October 31, 2020 0.066M
July 31, 2020 0.28M
Date Value
April 30, 2020 0.685M
January 31, 2020 -0.222M
October 31, 2019 0.673M
July 31, 2019 -0.125M
April 30, 2019 1.028M
January 31, 2019 0.714M
October 31, 2018 0.081M
July 31, 2018 0.528M
April 30, 2018 -2.455M
January 31, 2018 -2.439M
October 31, 2017 -3.643M
July 31, 2017 -3.993M
April 30, 2017 -3.606M
January 31, 2017 -4.164M
October 31, 2016 -4.188M
July 31, 2016 -6.686M
April 30, 2016 -6.787M
January 31, 2016 -8.085M
October 31, 2015 -9.616M
July 31, 2015 -9.502M
April 30, 2015 -9.751M
January 31, 2015 -7.68M
October 31, 2014 -7.035M
July 31, 2014 -4.331M
April 30, 2014 -3.694M

Free Cash Flow Range, Past 5 Years

View Free Cash Flow Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Free Cash Flow Benchmarks

View Free Cash Flow Benchmarks
Start Trial
Medpace Holdings, Inc. 706.69M
Avantor, Inc. 454.70M
Personalis, Inc. -100.98M
Adaptive Biotechnologies Corp. -24.03M
10X Genomics, Inc. 121.44M